Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery

9Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To report two cases of chronic postoperative cystoid macular edema, resistant to topical therapy, treated with consecutive intravitreal injections of ketorolac tromethamine. Methods: Four daily intravitreal injections of 500 μg/0.05 mL of ketorolac were given to each patient. Complete clinical examination and OCT were performed before every injection, 1, 2, 3 weeks, and 1, 3, and 6 months after the last injection. Fluorescein angiography was performed at baseline examination, 1, 3, and 6 months after the last injection. Results: In both cases, the edema regressed and visual acuity increased. At 6 months after the last injection, the leakage was significantly reduced at the fluorescein angiography. Discussion: Both cases responded favorably to the consecutive intravitreal administration of ketorolac tromethamine. The long-lasting remission of the macular edema in these chronic cases underlines the therapeutic potential of these agents when delivered intravitreally.

Cite

CITATION STYLE

APA

Tsilimbaris, M. K., Tsika, C., & Kymionis, G. D. (2016). Intravitreal ketorolac for the treatment of chronic cystoid macular edema after cataract surgery. Therapeutics and Clinical Risk Management, 12, 177–182. https://doi.org/10.2147/TCRM.S97342

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free